Lect 5 Flashcards

1
Q

PTH effects on Ca and phos

A

increase in serum Ca

decrease in serum phos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Vit D effects on Ca and phos

A

increase in serum Ca

increase in serum phos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Calcitonin

A

decrease in serum Ca

decrease in serum phos

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

loss of nephrons

A

increased phos retention

decreased prod of 1,25 DH D3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

secondary hyperparathyroidism

A

HD pts= PTH >495 pg/mL assoc w/ increased sudden death, increased morbidity and mortality

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

corrected Ca

A

Ca(corr)= [(4-albumin) x 0.8] + Ca(obs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

soft tissue calcification

A

rate is high when Ca x P >70 mg2/dL2
uncommon below 50 mg2/dL2
recommended to maintain below 55 mg2/dL2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

elevated Ca x P assoc with ___

A

vascular calcification, CV disease, calciphylaxis, death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

reference range of Ca

A

8.5-10.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

goal Ca for CKD stages

A

for all stages= w/in reference range

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

hypocalcemia

A

serum Ca less than 8.5

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

sx of hypocalcemia

A

depend on acuity of onset
acute= neuromuscular, CV
chronic= CNS, dermatologic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

WHAT MEDS COMMONLY CAUSE HYPOCALCEMIA?

A

bisphosphonates, calcitonin, furosemide, oral phosphorus therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

common causes of hypoCaemia

A

ICU, elderly, malnourished, pts who have received sodium phos as bowel prep, Vit D deficiency, parathyroidectomy or thyroidectomy, drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

treatment for acute, symptomatic hypocalcemia

A

100-300 mg elemental Ca IV over 5-10 min (should not be infused faster than 60 mg/min due to cardiac dysfunction)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

treatment for asymptomatic hypocalcemia

A

oral calcium 1-3 g/day

correct underlying cause if possible (replace Mg, replace Vit D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

treatment for acute, symptomatic hypocalcemia

A

100-300 mg elemental Ca IV over 5-10 min (should not be infused faster than 60 mg/min due to cardiac dysfunction)
continuous infusion 0.5-2 mg/kg/hr elemental Ca

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

treatment for asymptomatic hypocalcemia

A

oral calcium 1-3 g/day

correct underlying cause if possible (replace Mg, replace Vit D)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

hypercalcemia

A

serum Ca >10.5 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

sx of hypercalcemia

A

Ca less than 13= asymptomatic
Ca >13= depends on acuity of onset
acute= anorexia, N/V, constipation, polyuria/dipsia; hypercalcemic crisis (acute elevation to >15 mg/dL)
chronic= metastatic calcification, nephrolithiasis, chronic renal insuffienciency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

sx of hypercalcemia

A

Ca 13= depends on acuity of onset
acute= anorexia, N/V, constipation, polyuria/dipsia; hypercalcemic crisis (acute elevation to >15 mg/dL)
chronic= metastatic calcification, nephrolithiasis, chronic renal insuffienciency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

common causes of hyperCaemia

A

malignancy, primary hyperparathyroidism, meds

23
Q

common drug causes of hyperCaemia

A

Vit D analogs, Ca supplements, lithium

24
Q

tx for hyperCaemia

A
  • rehydration with NS 200-300 mL/h
  • loop diuretics: furosemide 40-80 mg IV Q1-4h
  • calcitonin 4 units/kg SQ or IM Q12h (use when hydration is C/I)= use in hemodialysis or ESRD
  • bisphosphonates: zoledronate 4-8 mg IV given over 5 min
25
Q

hypophosphatemia causes

A

decreased GI absorption (phos binders, sucralafate)
increased urinary excretion
extracellular to intracellular redistribution (refeeding syndrome)

26
Q

hypophosphatemia symptoms

A
mild-mod= aysymptomatic
severe= arrhythmias, resp muscle fatigue/ failure, myalgias, weakness, coma
27
Q

treatment for severe symptomatic hypophosphatemia

A

phos 15-30 mmol IV over 3 hours

28
Q

causes of hyperPhosemia

A

renal failure

intracellular phos release (tumor lysis syndrome)

29
Q

sx of hyperphosphatemia

A

soft tissue calcification
N/V, diarrhea, lethargy, seizures
renal osteodystrophy

30
Q

phos restriction

A

restrict to 800-1000 mg/day when:
phos levels >4.7 mg/dL
plasma conc of PTH elevated above target

31
Q

reference range for phos

A

2.6-4.5

32
Q

calcium citrate

A

phos binder

not to be used concurrently w/ aluminum-based binders

33
Q

aluminum-based phos binders

A

slowly removed by dialysis so can accumulate in various tissues
toxicity treated with deferoxamine

34
Q

aluminum-based phos binders

A

slowly removed by dialysis so can accumulate in various tissues
toxicity treated with deferoxamine

35
Q

when are non-Ca, non-Mg, non-Al based binders first line?

A

when hypercalcemic, low PTH, or vascular calcification

36
Q

examples of non-Ca, non-Mg, non-Al based binders

A
  • sevelamer HCl (Renagel)= lowers LDL, increases HDL; should not be broken or chewed
  • lanthanum carbonate (Fosrenol)= chewable wafer
37
Q

when is it ok to use aluminum-based binders?

A

in pts with phos >7 mg/dL, they may be used for less than 4 weeks

38
Q

Stage 3 & 4 phos binders first line

A

calcium-based

39
Q

Stage 5 primary phos binder therapy

A

either calcium-based binders OR non-Ca, non-Mg, non-Al based binders
can use combo if monotherapy ineffective

40
Q

stage 5 use of calcium binders

A

total daily dose of elemental Ca should not exceed 2 g/day (1500 mg phos binder, 500 mg diet)

41
Q

when do you start a Vit D COMPOUND in CKD?

A

Stage 3 or 4

when serum conc of 25-hydroxyvitamin D is less than 30

42
Q

when do you start a Vit D STEROL in CKD?

A

serum conc of 25(OH)D less than 30 and PTH is above target range
when PTH is progressively increasing and remain persistently higher than the upper reference limit
only in pts with Ca and phos at goal
do not use in rapidly worsening kidney function or non-compliant

43
Q

when is it ok to use aluminum-based binders?

A

in pts with phos >7 mg/dL, they may be used for

44
Q

which Vit D therapies are compounds?

A

ergocalciferol and cholecalciferol

45
Q

which Vit D therapies are sterols?

A

calcitriol, paricalcitol, doxecalciferol

46
Q

ADR’s of Vit D tx

A

increased intestinal absorption of Ca and phos (can lead to hyperCaemia or aggravate hyperPhosemia)
decreased PTH –> adynamic dbone disease

47
Q

when do you start a Vit D COMPOUND in CKD?

A

Stage 3 or 4

when serum conc of 25-hydroxyvitamin D is

48
Q

when do you start a Vit D COMPOUND in CKD?

A

Stage 3 or 4

when serum conc of 25-hydroxyvitamin D is

49
Q

when do you start a Vit D STEROL in CKD?

A

serum conc of 25(OH)D target range
when PTH is progressively increasing and remain persistently higher than the upper reference limit
only in pts with Ca and phos at goal
do not use in rapidly worsening kidney function or non-compliant

50
Q

PTH reference ranges

A

Stage 3-5= 35-70

Stage 5 dialysis= 130-600

51
Q

calcimimetics (cinacalet HCl)

A

decrease PTH secretion and Ca x P

majority of pts receiving concurrent Vit D and phos binders

52
Q

ADR’s of calcimimetics

A

N/V, hypoCaemia
inhibitor of CYP2D6
take with meals

53
Q

calcimimetics place in therapy

A

alternative or adjunct to Vit D analogs